The publications listed within this section represent a sampling of scientific papers, abstracts and presentations that the Baim Institute’s faculty have authored and that are the direct result of clinical research conducted at the Baim Institute. 




Showing : 16 of 23

Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry.

01/23/2018

Singh A, Collins BL, Gupta A, Fatima A, Qamar A, Biery D, Baez J, Cawley M, Klein J, Hainer J, Plutzky J, Cannon CP, Nasir K, Di Carli MF, Bhatt DL, Blankstein R.

Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes.

01/16/2018

Garlo KG, White WB, Bakris GL, Zannad F, Wilson CA, Kupfer S, Vaduganathan M, Morrow DA, Cannon CP, Charytan DM.

Association of insurance type with receipt of oral anticoagulation in insured patients with atrial fibrillation: A report from the American College of Cardiology NCDR PINNACLE registry.

01/01/2018

Yong CM, Liu Y, Apruzzese P, Doros G, Cannon CP, Maddox TM, Gehi A, Hsu JC, Lubitz SA, Virani S, Turakhia MP; ACC PINNACLE Investigators..

A Prospective Randomized Trial of Apixaban Dosing During Atrial Fibrillation Ablation

12/21/2017

The AEIOU Trial Matthew R. Reynolds , J. Scott Allison , Andrea Natale , Ian L. Weisberg , Kenneth A. Ellenbogen , Mark Richards , Wen-Hua Hsieh , Julie Sutherland and Christopher P. Cannon

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT.

12/20/2017

Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbalan R, Spinar J, Park JG, White JA, Bohula E, Braunwald E; IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators ..